Patient dosimetry during chest, abdomen, skull and neck radiography in SW Nigeria
Article Outline
- Abstract
- Introduction
- Materials and methods
- Results
- Discussion
- Conclusion
- Acknowledgements
- References
- Copyright
Abstract
The technique factors and X-ray output from the X-ray units of three Nigerian hospitals were obtained and used to calculate doses delivered to patients during chest, abdomen, skull and neck examinations. DoseCal software was used to calculate the entrance skin dose (ESD) and effective dose (E) based on the values of technique factors employed. The result obtained for inter-hospital comparison showed wide variation of mean hospital ESD, from a factor of 1.3 for chest posteroanterior (PA) in hospital 2 (H2) to a factor of 63 for the same chest X-ray projection in hospital 1 (H1). A comparison of ESD obtained in this work with established reference doses in the United Kingdom (UK 2005 review), International Atomic Energy Agency (IAEA), Community of European Commission (CEC), Ghana and Sudan shows that the values of ESD obtained in H1 for five examinations; namely: chest (PA) and lateral (LAT), abdomen anteroposterior (AP) and skull (PA and LAT) are higher. In H2, the dose value for chest PA is about 50% higher than that of UK but comparable with CEC and less than IAEA and Ghanaian values. The dose values obtained in H3 chest PA are higher than UK, IAEA and CEC values but comparable with that of Ghana. For abdomen AP, the dose is a factor of 1.2 less than IAEA and CEC values but greater than the UK, Ghanaian and Sudanese values by a factor of 2.1, 1.2 and 4.5, respectively. Reference data for abdomen LAT and neck AP were not available for comparison. Higher effective doses are being delivered to patients in chest PA (H1 and H3) and abdomen AP (H1) when compared with the range of values reported in the literature. This trend is an indication that patients examined are at higher health risks.
Keywords: Entrance surface dose, Chest, Abdomen, Skull, Radiological, Neck
Introduction
Due to the continual leading role of X-rays as an important diagnostic tool in modern healthcare, it serves as a significant source of radiation exposure to both patient and medical personnel.1 It is estimated that diagnostic radiology and nuclear medicine contributed 88% to the collective effective dose from man-made source in the US,2 while in the UK similar contribution was 96%.3 The need for determination or at least a realistic estimation of radiation dose to patients during X-ray examinations in every hospital as well as compared with reference doses established by competent regulatory authorities has been emphasized in the literature.4, 5
Based on the important knowledge of the dose absorbed and the consequences of the absorbed dose, National Occupation Health and Safety Commission (NOHSC, 1995)6 indicated that dose assessment of employees and members of the public is required and appropriate to ensure compliance with recommendation. Although diagnostic imaging using X-rays produces a net benefit, the potential for radiation induced injury to the patient exists. Therefore, understanding absorbed doses and the factors that affect them is very important.7, 8, 9, 10, 11 Earlier publications have indicated that radiation doses are affected by technique factors, patient characteristics, filtration, projection type and age of the machine.10 Therefore, through proper choice of technique factors, dose reduction is possible while maintaining the image quality during radiographic examinations.
The classification of United Nations Scientific Committee on the Effects of Atomic Radiation12 shows that, Nigeria is in healthcare level IV category. This is an indication that the physician–patient ratio is higher than in healthcare level II countries with 1000–3000 persons per physician; consequently, there is no adequate information on patient doses in healthcare level IV countries as required by the international regulatory bodies. Earlier dose measurements in Nigeria have been carried out by few researchers13, 14, 15 using direct method of dose assessment. However, only Ogundare et al. documented the technique factors, patient characteristics and attempted calculating the effective doses while others dwelt on entrance skin doses. As far as we know all these researchers obtained part of their data from University College Hospital, Ibadan and few hospitals within and outside Ibadan. More recent studies on dose measurements have been carried out in southeastern Nigeria using thermoluminescent dosimeters (TLDs)16 and a mathematical method.17
The aim of this study is to evaluate the radiation doses to patients undergoing some common diagnostic X-ray examinations in three large hospitals in SW Nigeria. Part of the aim is to assess the radiographic techniques used during the different examinations. It was anticipated that the study will help in the optimization of radiation protection of the patient. Information from this dose evaluation will serve as a useful baseline against which assessment at an individual X-ray department may be compared. The doses and technique factors reported in this work will be useful for the Nigerian Nuclear Regulatory Authority (NNRA) and other regulatory bodies when exploring the possibility of dose reduction and the assessment of radiographic practices in Nigerian hospitals. The patient dose was estimated in the present study in terms of entrance skin dose (ESD) and effective dose (E). Estimated ESDs and Es were compared with the reference doses found in Africa and Europe. Analysis of dose distributions among different radiological departments under study was also performed.
Materials and methods
In this study, technique factors, that is, kVp, mA
s, FSD and patient characteristics such as weight, height, age, and thickness of the irradiated regions were obtained for chest, abdomen, skull and neck radiographic examinations. These data were recorded for each patient undergoing the specified diagnostic examinations. The data were collected in three different hospitals which include one teaching hospital (H1), one private hospital (H2) and one state hospital (H3), all located in three large cities of southwestern Nigeria namely Osogbo (Osun state), Ibadan (Oyo state) and Ijebu Ode (Ogun state). A total of 209 adult (above 16 years) patients undergoing routine X-ray examinations were considered in this study.
Three different X-ray units were included in this study. They were all analogue systems installed at different times as presented in Table 1. The films were examined and considered acceptable to the radiologists/radiographers after exposure and film processing. This ensured that all dose levels used were representative of diagnostic image.
Table 1. Specific data of machines used at selected hospitals
| Hospital code | Name of machine | Year of installation | X-ray output (mGy/mA | Effective kVp | Filtration (mm Al) |
|---|---|---|---|---|---|
| H1 | Neo Diagnomax | 1982 | 7.9 | 89.8 | 3.0 |
| H2 | Aicoma | 2005 | 5.6 | 97.1 | 1.0 |
| H3 | GEC Apollo | 1984 | 2.7 | 94.5 | 2.0 |
The output of the X-ray machines (in mGy/mA
s) at 80
kVp at a distance of 1
m normalized to 10
mAs10 was measured using a calibrated KV meter (Victoreen invasive X-ray test device model 4000 m+).
Indirect measurement of entrance skin dose (ESD) and effective dose (E) was carried out in this study. This involved the use of technique factors, output of the X-ray machine and the backscatter factors for adult. The DoseCal software18 was used to calculate ESD and E based on the values of technique factors employed, that is, the X-ray tube output and the projections. This method of dose calculation is a realistic alternative to dosimetry methods such as thermoluminescence dosimetry (TLD).10 The DoseCal software was developed in the Radiological Protection Centre of Saint George’s Hospital (London) and plays an essential role in the evaluation of radiation doses for a great number of patients. For the operation of the software, X-ray outputs in mGy/mA
s at 80
kV at a distance of 100
cm normalized to 10
mA
s were entered and when kVp (in kilovolts), mA
s (product of tube current and exposure time), FSD (focus to skin distance in cm), BSF (backscatter factor) are known, Eq. (1) demonstrates the ESD.19
(1)Results
The data were collected in three major hospitals in SW Nigeria, comprising three X-ray facilities. Table 1 shows the specific data of the three X-ray units used for this study. The filtration of the X-ray units in H2 and H3 was found to be lower than 2.5
mm Al prescribed by the National Radiological Protection Board (NRPB). Patient information and technique factors for chest posteroanterior (PA) and lateral (LAT), abdomen anteroposterior (AP) and LAT, skull PA and LAT and neck AP examinations in the three hospitals (H1, H2 and H3) investigated are shown in Table 2. All the three X-ray units under study undertook the chest PA examination but only hospital H1 undertook chest LAT examination. Two hospitals undertook the abdomen AP examination while again only hospital H1 undertook abdomen LAT examination. Two hospitals (H1 and H3) undertook skull (PA and LAT) examination and only hospital H1 undertook neck AP examination.
Table 2. Patient information and technique factors for different X-ray examinations (range in parentheses)
| Radiograph (hospital) | Projection | Thickness (cm) | Height (cm) | Weight (kg) | Body mass index (kg | Tube potential (kVp) | Mean (mA | FSD (cm) |
|---|---|---|---|---|---|---|---|---|
| Chest (H1) | PA | 20 (12–30) | 166 (133–192) | 62 (35–91) | 23 (14–36) | 66 (16–80) | 20 (8–100) | 105 (55–100) |
| Chest (H2) | PA | 21 (17–25) | 167 (148–182) | 61 (46–77) | 22 (17–28) | 80 (constant value used) | 15 (constant value used) | 129 (125–133) |
| Chest (H3) | PA | 23 (20–26) | 164 (116–181) | 68 (48–170) | 26 (19–48) | 85 (75–90) | 9 (constant value used) | 125 (66–157) |
| Chest (H1) | LAT | 26 (15–33) | 165 (149–176) | 61 (37–91) | 23 (14–41) | 71 (63–90) | 23 (15–40) | 96 (63–114) |
| Abdomen (H1) | AP | 23 (16–34) | 169 (157–176) | 68 (55–97) | 24 (18–39) | 76 (70–90) | 131 (100–250) | 85 (60–110) |
| Abdomen (H3) | AP | 24 (20–28) | 163 (151–173) | 65 (52–82) | 25 (19–27) | 106 (100–120) | 27 (16–45) | 91 (47–178) |
| Abdomen (H1) | LAT | 34 (19–48) | 167 (157–176) | 73 (55–95) | 27 (18–39) | 83 (67–100) | 150 (80–200) | 69 (49–111) |
| Skull (H1) | PA | 21 (16–27) | 165 (152–182) | 71 (48–109) | 26 (18–43) | 76 (60–85) | 106 (82–160) | 95 (67–132) |
| Skull (H1) | LAT | 16 (11–23) | 162 (152–182) | 71 (48–100) | 28 (18–43) | 74 (60–100) | 69 (10–100) | 98 (66–118) |
| Neck (H1) | AP | 12 (10–14) | 160 (154–170) | 72 (59–91) | 28 (18–43) | 70 (67–72) | 28 (16–40) | 91 (74–104) |
The median patient weight measured was found to be 67
kg. This median patient size was within the range of a standard sized person of 60–80
kg recommended by the Community of European Commission (CEC).21 It can be seen from Table 2 that a constant value of tube potential of 80
kVp was used for chest PA examination in H2. Hospital H1 was using low kVp, ranging between 16 and 80
kVp, with a median of 66
kVp for chest PA examination. Both high-kVp and low-kVp radiological techniques were reported to be commonly used in chest radiography examinations in Europe and USA.22 However, CEC recommends that kVp in the range 100–150
kVp be used for chest PA examinations which results in low doses.
In H1, the mean FSD as low as 105
cm was used for chest PA examination. As a result, higher ESDs were encountered in this hospital. The use of optimum FSD is considered very important, since there is a direct relationship between shorter FSD, higher patients’ dose and decreased geometric sharpness.23, 24 It is also evident from the table that a constant value of 15
mA
s and 9
mA
s were used in H2 and H3, respectively, for patients of various sizes during chest examination.
Table 3 is a comparison of patient information and technique factors with Ghana, UK, CEC and the combination of European and Asian values. The mean value of thickness of the chest of the patient was comparable to Ghanaian value of 20
cm while the mean thickness of the abdomen of the patient of 23
cm in H1 is higher than that of Ghana. It is clear from the procedural data shown that where guidelines are available, the three hospitals are not complying with international guidelines for some parameters.
Table 3. Comparison of patient information and technique factors (adult) with Ghanaian, UK, EC and European–Asian values
| Patient information and technical parameters | Radiograph | This work | Ghanaa | UK (NRPB)a | CECa | European–Asianb |
|---|---|---|---|---|---|---|
| Patient thickness (cm) | Chest PA | 20 (12–30) H1 | 20 (13–33) | – | – | – |
| 21 (17–25) H2 | ||||||
| 23 (16–34) H3 | ||||||
| Abdomen AP | 23 (16–34) H1 | 19.6 (15–28) | – | – | – | |
| 24 (20–28) H3 | ||||||
| Applied tube potential (kVp) | Chest PA | 66 (16–81) H1 | 70.1 (50–90) | 76 (44–150) | 100–150 | 70–125 |
| 80 (constant) H2 | ||||||
| 85 (75–90) H3 | ||||||
| Chest LAT | 71 (63–90) H1 | – | – | – | 101–125 | |
| Abdomen AP | 76 (70–90) H1 | 78.1 (65–90) | 73 (55–120) | 70–90 | 66–84 | |
| 106 (100–120) H3 | ||||||
| Skull PA | 76 (60–85) H1 | – | – | 65–85 | – | |
| Focus to skin distance (FSD) (cm) | Chest PA | 105 (55–100) H1 | 152 (41–201) | – | – | 150–180 |
| 129 (125–33) H2 | ||||||
| 125 (66–157) H3 | ||||||
| Chest LAT | 96 (63–114) H1 | – | – | – | 180 | |
| Abdomen AP | 85 (60–110) H1 | 84.1 (60–107) | – | – | 100–115 | |
| 91 (47–178) H3 | ||||||
| Skull PA | 95 (67–132) H1 | – | – | 100–150 | – | |
| Product of tube current and exposure time (mA | Chest PA | 20 (80–100) H1 | 32.7 (8–90) | 8 (1–200) | – | 1.4–4.7 |
| 15 (constant) H2 | ||||||
| 9 (constant) H3 | ||||||
| Chest LAT | 23 (15–40) H1 | – | – | – | 4.4–20.7 | |
| Abdomen AP | 131 (100–250) H1 | 83.1 (40–26) | 53 (3–400) | – | 12–63 | |
| 27 (16–45) H3 |
The distribution and mean values of ESD for different examinations and hospitals are presented in Table 4. Wide variations are demonstrated between hospitals. Minimum/maximum ratio of ESD for mean hospital dose ranged from 1.3 for chest PA in H2 to 63 for the same projection in H1. For abdomen AP, the range of mean hospital dose varies from a factor of 6.4 in H3 to a factor of 11.8 in H1.
Table 4. Distribution of individual entrance skin dose (ESD)
| Examination | Projection | No. of patients | Entrance skin dose (mGy) | Min./max. ratio | |||
|---|---|---|---|---|---|---|---|
| Min. | Mean | Max. | Standard deviation (SD) | ||||
| Chest (H1) | PA | 70 | 0.1 | 1.4 | 6.3 | 0.9 | 63.0 |
| Chest (H2) | PA | 40 | 0.3 | 0.3 | 0.4 | 0.0 | 1.3 |
| Chest (H3) | PA | 12 | 0.4 | 0.6 | 1.6 | 0.4 | 4.0 |
| Chest (H1) | LAT | 11 | 0.9 | 2.0 | 3.2 | 0.7 | 3.6 |
| Abdomen (H1) | AP | 10 | 7.0 | 23.4 | 82.4 | 23.3 | 11.8 |
| Abdomen (H3) | AP | 10 | 1.4 | 8.5 | 9.0 | 3.6 | 6.4 |
| Abdomen (H1) | LAT | 10 | 9.6 | 46.5 | 91.2 | 26.8 | 9.5 |
| Skull (H1) | PA | 25 | 6.7 | 12.1 | 26.4 | 5.4 | 3.9 |
| Skull (H1) | LAT | 11 | 0.4 | 8.5 | 24.1 | 7.5 | 60.3 |
| Neck (H1) | AP | 10 | 1.6 | 2.7 | 3.6 | 0.9 | 2.3 |
Discussion
Variation in FSD, mA
s and kVp used among the three hospitals is a reflection of non standardization of procedures.10 Variations of exposure factors were also found within the same hospital. The kVp for chest PA projection ranged from 16 to 80
kVp in H1, while the mA
s varied from 8 to 100
mA
s for the same projection. The radiologists in this hospital prefer higher contrast chest radiographs which result from low kVp.25 The low kVp here indicates poor practice and shows that the focus of radiographers is just the image quality at the expense of patient dose. The FSD varied from 55 to 100
cm in H1, 125–133
cm in H2 and 66–157
cm in H3.
It is worthy of note that the constant value of mA
s used in both H2 and H3 for patients of various sizes is far from good practice since it is necessary to account specifically for patient weight when setting the technique factors. Failure to account specifically for patient weight (especially when there is no automatic exposure control – AEC)28 during radiographic examinations could lead to patients of small weight being unnecessarily exposed and patients of large weight being under exposed.29 This could produce suboptimal image quality.30 It is interesting to observe that the mA
s values used in H3 (for abdomen AP) were lower than the mean value used in both Ghana and the UK.
The tube filtrations found in the three hospitals (as seen in Table 1) show that only H1 with filtration of 3.0
mm Al exceeded the minimum standard of 2.5
mm Al prescribed in the UK standard.7, 11 Due to the low filtration found in H2, the effective dose could not be calculated since the NRPB report did not provide data for filtration of 1
mm Al. The facility with this lowest filtration in this study is in a private hospital. There was probably a lack of adequate information about the required minimum filtration.
As regards the FSD for all the examinations, the three hospitals did not comply with international guidelines. The values were found to be lower in all cases. Also, the mean value of mA
s used for chest PA in hospital H1 was found to be within the range of UK values. For abdomen AP and chest LAT, the hospitals did not comply with international guidelines. Reference values for skull LAT, abdomen LAT and neck AP were not available for comparison.
The range of mean hospital dose varies from a factor of 1.3 to a factor of 63 for the anteroposterior chest (Table 4). An Irish study showed a hospital dose variation from a factor of 3 for the lumbar spine AP to a factor of 23 for the chest PA.32 An inter-hospital comparison shows that the mean ESD calculated for chest PA (H1) is higher than the value found in H2 and H3 by a factor of 4.7 and 2.3, respectively. Also in abdomen AP, the ESD calculated in H1 is higher than that of H3 by a factor of 2.8. The mean values obtained for skull (PA), skull (LAT) and neck (AP) were 12.1, 8.5 and 2.7
mGy, respectively. The highest value of 46.5
mGy is recorded in abdomen LAT in H1. This high value could be attributed to the large tube current–time product of 150
mA
s used. Apparently, the quality of the image produced is primed above patient safety. Because of this, education of the radiologist and radiographer about the specific factors that affect radiation doses to patients as well as the steps that could be taken to minimize such doses is essential.11 This would help to optimize the dose–image quality relationship. The trend found in H2 and H3 in the choice of technique factors shows that the technique factors are not matched with patients’ weights. This could be due in part to the absence of a chart that suggests radiographic technique factors for various examinations and patients’ thicknesses.
Table 5 is a comparison of ESD obtained in this work with established reference doses in the UK (2005 review), IAEA, EC, Ghana and Sudan. In this comparison, the values of ESD obtained in H1 for five examinations namely chest (PA and LAT), abdomen (AP) and skull (PA and LAT) are higher than those of UK, IAEA, EC, Ghana and Sudan. The ESD for chest PA was found to be higher than UK values by a factor of 9.3; skull (PA and LAT) were higher than UK and Sudanese values by factors 6.1 and 6.5, respectively while abdomen AP was a factor of 5.6 and 12.3 higher than UK and Sudanese values, respectively. The chest (LAT) projection had the lowest variation with the UK, varying with a factor of 3.3. In H2, the ESD value for chest PA is about 50% higher than that of UK, comparable with EC but less than IAEA and Ghanaian values. The ESD values obtained in H3 for chest PA are higher than UK, IAEA and EC values but comparable with that of Ghana. For abdomen AP, it is a factor of 1.2 less than IAEA and EC values but greater than the UK, Ghanaian and Sudanese values by a factor of 2.1, 1.2 and 4.5, respectively. Reference data for abdomen LAT and neck AP were not available for comparison.
Table 5. Comparison of ESD (mGy) with international reference doses and those obtained in Ghana and Sudan for adults
| Examination | This work | UK (2005 review)a | IAEA (1996) | EC (1996) | Ghanab | Sudanb |
|---|---|---|---|---|---|---|
| Chest PA | 1.4 (H1) | 0.15 | 0.4 | 0.3 | 0.6 | – |
| 0.3 (H2) | ||||||
| 0.6 (H3) | ||||||
| Chest LAT | 2.0 (H1) | 0.6 | 1.5 | 1.5 | – | – |
| Abdomen AP | 23.4 (H1) | 4 | 10.0 | 10.0 | 7.2 | (1.3–1.9) |
| 8.5 (H3) | ||||||
| Abdomen LATc | 46.5 (H1) | – | – | – | – | |
| Skull PA | 12.1 (H1) | 2 | 5.0 | 5.0 | 5.8 | (1.0–2.3) |
| Skull LAT | 8.5 (H1) | 1.3 | 3.0 | 3.0 | – | (0.3–1.3) |
| Neck APc | 2.7 (H1) | – | – | – | – |
cNo reference data for comparison. |
Table 6 presents the minimum, maximum, mean and standard deviation of effective dose obtained in this study. The mean effective doses and ranges for chest PA, chest LAT, abdomen AP, skull PA and skull LAT projections were found to be 0.2 (0.0–0.6), 0.1 (0.1–0.2), 3.2 (0.8–11.8), 0.1 (0.1–0.3) and 0.1 (0.0–0.3) mSv, respectively. Table 7 shows the comparison of this work’s mean effective dose with the ranges of effective doses reported in the literature for the different examinations and procedures.
Table 6. Summary of effective dose (E) for different examinations
| Examination | Effective dose (×10−1 | |||
|---|---|---|---|---|
| Min. | Mean | Max. | Standard deviation (SD) | |
| Chest PA (H1) | 0.1 | 1.5 | 6.1 | 0.8 |
| Chest PA (H3) | 0.4 | 0.7 | 1.6 | 0.4 |
| Chest LAT (H1) | 0.6 | 1.4 | 2.3 | 0.5 |
| Abdomen AP (H1) | 8.4 | 31.7 | 117.8 | 34.4 |
| Abdomen AP (H3) | 2.1 | 10.3 | 15.2 | 0.5 |
| Skull PA (H1) | 0.5 | 1.0 | 2.5 | 0.6 |
| Skull LAT (H1) | 0.4 | 0.9 | 2.7 | 0.8 |
Table 7. Comparison of effective dose (mSv) with doses reported in the literature
| Examination | This work | Values reported in literature (mSv)a |
|---|---|---|
| Chest PA | 0.2 (H1) | 0.007–0.050 |
| 0.1 (H3) | ||
| Chest LAT | 0.1 (H1) | 0.05–0.24 |
| Abdomen AP | 3.2 (H1) | 0.04–1.1 |
| 1.0 (H3) | ||
| Skull PA | 0.1 (H1) | 0.03–0.22 |
| Skull LAT | 0.1 (H1) |
Comparing the mean effective dose obtained in H1 with that of H3 shows that the mean effective dose in H1 is greater than the doses obtained in H3 by a factor of 2 and 1.4 for chest PA and abdomen AP, respectively. The comparison of mean effective dose obtained in H1, for chest PA and abdomen AP with the reference doses reported in the literature indicates that the effective dose calculated in this study is greater than the established reference doses by 33% in both projections. For skull (PA and LAT) examinations, the mean effective doses obtained in this study are within the range of values reported in the literature. Reference data for abdomen LAT and neck AP were not available. Comparison in H3 shows about 14% increase in the effective dose values for chest PA but the mean value for abdomen AP was found to be within the range of the values reported in the literature. The results of this study showed that higher effective doses are being delivered to patients in chest PA (H1 and H3) and abdomen AP (H1) when compared with the range of values reported in literature. Radiologists and radiographers in these hospitals have an obligation to balance the risks and benefits of these medical procedures.
Conclusion
The findings of this study clearly showed that both the ESD and E calculated in H1 and H3 were higher than UK (2005 review), IAEA and EC established reference doses elsewhere. However, the practices in H2 in most part agreed with the established reference doses but the filtration of 1
mm Al used is unacceptable. The trend found in H1 and H3 is an indication that there is a need to improve the quality of radiodiagnostic procedures in the hospitals.
In addition, radiation staff need awareness concerning the levels of dose and distribution of doses being delivered to patients undergoing various diagnostic procedures and the attendant risk to the population being exposed. Meanwhile, these results would be useful to the Nigerian Nuclear Regulatory Authority (NNRA) as baseline upon which future dose measurements may be compared and in the formulation of both local and national diagnostic reference levels. The findings of this work indicate the need for serious monitoring, quality assurance programme (QAP) in Nigeria and re-training of the personnel responsible for the exposure of patients.
Acknowledgements
The authors would like to thank the hospitals that participated in this study and their staff for their cooperation. They are also grateful to a staff of Fundacao Oswaldo Cruz (Fiocruz), Brazil for kindly providing the DoseCal software used for the present study. One of the authors who is an associate undertook part of this work with the support of “ICTP, Trieste, Italy”.
References
- . The use of Monte Carlo technique for the determination of tissue–air ratios (TAR) in diagnostic energy range. Phys Med. 1998;14:
- National Council on Radiation Protection and Measurements (NCRP). Ionizing radiation exposure of the population of the United States. NCRP report 93; 1987.
- National Radiological Protection Board (NRPB). A national survey of doses to patients undergoing a selection of routine X-ray examinations in English hospitals. NRPB report 261; 1993.
- . Patient dose reduction in diagnostic radiology. NRPB. 1990;1(3):
- Commission of European Communities (CEC). European Commission. European guidelines on quality criteria for diagnostic radiographic images in paediatrics. EUR 16261 EN; 1996.
- National Occupational Health and Safety Commission (NOHSC). Recommendations for limiting exposure to ionizing radiation. NOHSC: 3022 (Radiation health series 39); 1995.
- . The AAPM/RSNA physics tutorial for residents: typical patient radiation doses in diagnostic radiology. Radiographics. 1999;19:1289–1302
- . Doses to patients in routine X-ray examinations in Malaysia. Br J Radiol. 1998;71:654–660
- . The potential for reduction of radiation doses to patients undergoing some common X-ray examinations in Tanzania. Radiat Prot Dosimetry. 2001;94:381–384
- . Dose evaluation for paediatric chest X-ray examinations in Brazil and Sudan: low doses and reliable examinations can be achieved in developing countries. Phys Med Biol. 2004;49:1017–1031
- . Radiation effective doses to patients undergoing abdominal CT examinations. Radiology. 1999;210(3):645–650
- United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources, effects and risks of ionizing radiation. Vol. 2. Report to the General Assembly, with scientific annexes; 2000.
- . Comparison of entrance surface doses of some X-ray examinations with CEC reference doses. Radiat Prot Dosimetry. 2002;98(2):231–234
- . Measurement of entrance skin doses to patients in four common diagnostic examinations by thermoluminescence dosimetry in Nigeria. Radiat Prot Dosimetry. 2000;87:217–220
- . Radiological parameters and radiation doses of patients undergoing abdomen, pelvis and lumbar spine X-ray examinations in three Nigerian hospitals. Br J Radiol. 2004;77:934–940
- . A baseline study of entrance dose and image quality for lumbar spine radiography in Calabar, Nigeria. Radiography. 2008;15:306–312
- . Doses and image quality for chest radiographs in three Nigerian hospitals. Eur J Radiogr. 2009;1:30–36
- . Patient doses in diagnostic radiology at the touch of a button. London, UK: The Radiological Protection Centre, St George’s Hospital; 2000;
- . Patient dose audit in diagnostic radiography using custom designed software. Radiography. 1997;3:17–25
- Hart D, Jones DG, Wall BF. Normalised organ doses for medical X-ray examinations calculated using Monte Carlo techniques. NRPB-SR262; 1994.
- Commission of European Communities (CEC). European Commission. European guidelines on quality criteria for diagnostic radiographic images. EUR 16260 EN; 1996.
- . The effect of beam tube potential variation on gonad dose to patients during chest radiography investigated using high sensitivity LiF:Mg, Cu, P thermoluminescent dosemeters. Br J Radiol. 2001;74:358–367
- . Image quality and dose in lumbar spine examinations: results of a 5 year quality control programme following the European quality criteria trial. Br J Radiol. 1995;68:1332–1335
- . Increasing FFD: an effective dose-reducing tool for lateral lumbar spine investigations. Radiography. 1998;4:251–259
- . Implementation of a programme for reduction of radiographic doses and results achieved through increases in tube potential. Br J Radiol. 1993;66:228–233
- . Analysis of dose and dose distribution for patients undergoing selected X-ray diagnostic procedures in Ghana. Radiat Prot Dosimetry. 1998;76:249–255
- . CEC analysis of radiological images produced in Europe and Asia. Radiography. 2007;13:202–209
- International Commission on Radiological Protection (ICRP). Protection of the patient in diagnostic radiology. ICRP publication 34; 1982.
- . Mottle on computed radiographs of the chest in pediatric patients. Radiology. 1996;199:249–252
- . Technique factors and image quality as functions of patient weight at abdominal CT. Radiology. 2000;217:430–435
- Hart D, Hillier MC, Wall BF. Doses to patients from radiographic and fluoroscopic X-ray imaging procedures in the UK – 2005 review. Chilton, UK. HPA-RPD-029; 2007.
- . Reference dose levels for patients undergoing common diagnostic X-ray examinations in Irish hospitals. Br J Radiol. 2000;73:396–402
- . Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 2008;248:254–263
PII: S1078-8174(10)00059-3
doi:10.1016/j.radi.2010.05.009
© 2010 The College of Radiographers. Published by Elsevier Inc. All rights reserved.
